Publication: Computational approaches for the study of serotonin and its membrane transporter SERT: Implications for drug design in neurological sciences
Issued Date
2008-12-01
Resource Type
ISSN
09298673
Other identifier(s)
2-s2.0-61549119818
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Current Medicinal Chemistry. Vol.15, No.30 (2008), 3214-3227
Suggested Citation
J. Pratuangdejkul, B. Schneider, J. M. Launay, O. Kellermann, P. Manivet Computational approaches for the study of serotonin and its membrane transporter SERT: Implications for drug design in neurological sciences. Current Medicinal Chemistry. Vol.15, No.30 (2008), 3214-3227. doi:10.2174/092986708786848523 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/18825
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Computational approaches for the study of serotonin and its membrane transporter SERT: Implications for drug design in neurological sciences
Other Contributor(s)
Abstract
Serotonin (5-hydroxytryptamine, 5-HT), a monoamine neurotransmitter of the central nervous and peripheral systems (CNS), plays a critical role in a wide variety of physiological and behavioral processes. In the serotonergic system, deregulation of the tightly controlled extracellular concentration of 5-HT appears to be at the origin of a host of metabolic and psychiatric disorders. A key step that regulates 5-HT external level is the re-uptake of 5-HT into cells by the 5-HT transporter (SERT), which is besides the target of numerous drugs interacting with the serotonergic system. Therapeutic strategies have mainly focused on the development of compounds that block the activity of SERT, for instance reuptake inhibitors (e.g. tricyclics, "selective" serotonin reuptake inhibitors) and in the past, specific substrate-type releasers (e.g. amphetamine and cocaine derivatives). Today, generation of new drugs targetting SERT with enhanced selectivity and reduced toxicity is one of the most challenging tasks in drug design. In this context, studies aiming at characterizing the physicochemical properties of 5-HT as well as the biological active conformation of SERT are a prerequisite to the design of new leads. However, the absence of a high-resolution 3D-structure for SERT has hampered the design of new transporter inhibitors. Using computational approaches, numerous efforts were made to shed light on the structure of 5-HT and its transporter. In this review, we compared several in silico methods dedicated to the modeling of 5-HT and SERT with an emphasis on i) quantum chemistry for study of 5-HT conformation and ii) ligand-based (QSAR and pharmacophore models) and transporter-based (homology models) approaches for studying SERT molecule. In addition, we discuss some methodological aspects of the computational work in connection with the construction of putative but reliable 3D structural models of SERT that may help to predict the mechanisms of neurotransmitter transport. © 2008 Bentham Science Publishers Ltd.